Rare diseases
Investigational molecules
Locations
Back to Italy28 clinical trials in Castellana Grotte, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
ItalyLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
ItalyStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
ItalyA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
ItalyStudy of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
ItalyStudy of precemtabart tocentecan alone or in drug combination versus standard therapy in previously treated metastatic colorectal cancer patients
ItalyA study of rilvegostomig, cisplatin, and gemcitabine compared to durvalumab and a drug combination for adults with advanced biliary tract cancer
ItalyA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
ItalyStudy of icotrokinra for adults with moderately to severely active Crohn's disease
ItalyComparing irinotecan plus cetuximab with trifluridine and tipiracil plus bevacizumab for patients with metastatic colorectal cancer as third line treatment
ItalyStudy of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis
ItalyStudy on Cetuximab and Drug Combination for Patients with Metastatic Colorectal Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on metastatic colorectal cancer treatments, particularly evaluating the effectiveness of targeted therapies and biomarker-driven approaches.
Multiple trials are exploring novel therapeutic strategies for patients with RAS/BRAF mutations.
Comprehensive research into moderate to severe Crohn's disease, investigating new treatment options and maintenance therapies.
Trials focus on both innovative medications and disease management after surgical interventions.
Advanced studies examining treatments for moderately to severely active ulcerative colitis, with emphasis on long-term efficacy and symptom management.
Research aims to improve quality of life through innovative treatment approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
